Hostname: page-component-7b7567c8c-w7t8q Total loading time: 0 Render date: 2026-11-19T01:47:17.145Z Has data issue: false hasContentIssue false

Frontal Lobe Dysfunction and Impulse Control Problems as a Neuropsychiatric Manifestation of Progressive Multiple Sclerosis: A Case Report

Published online by Cambridge University Press:  31 July 2026

T. Üğüden*
Affiliation:
Department of Psychiatry
Y. Çiçek
Affiliation:
Department of Psychiatry
N. G. Usta Sağlam
Affiliation:
Department of Psychiatry
F. S. Bayır
Affiliation:
Department of Neurology, Istanbul University-Cerrahpasa , Cerrahpasa Medical Faculty, Istanbul, Türkiye
M. Tütüncü
Affiliation:
Department of Neurology, Istanbul University-Cerrahpasa , Cerrahpasa Medical Faculty, Istanbul, Türkiye
S. Turan
Affiliation:
Department of Psychiatry
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Introduction

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system characterized by sensory and motor deficits and a wide spectrum of neuropsychiatric manifestations, including mood disorders, cognitive decline and behavioral disinhibition.Impulse control problems are rare but clinically relevant, as they may mimic primary neurodegenerative syndromes and complicate management.

Objectives

We present a patient with MS with a progressive course and bilateral frontal lobe involvement manifesting impulsive and disinhibited behaviors. This case highlights the importance of recognizing MS-related neurodegeneration as a potential cause of dysexecutive syndromes and distinguishing it from frontotemporal dementia (FTD).

Methods

Psychiatric assessment included a mental status examination, neuropsychological testing and the Barratt Impulsiveness Scale–Short Form (BIS-11-SF). Neurological evaluation comprised lumbar puncture and cranial MRI.

Results

A 57-year-old man presented with three years of progressively worsening inappropriate spending, perseverative gambling, and compulsive hoarding. His psychiatric history included irritability and aggression treated in 2016, and he was most recently on escitalopram 20 mg/day and mirtazapine 30 mg/day.On examination, he displayed indifference, delayed responses due to word-finding difficulty, impaired attention, apathetic mood, restricted affect, and poor abstraction, while other cognitive functions were relatively preserved and no psychotic features were observed. Neuropsychological testing demonstrated slowed mental control, impaired attention and markedly reduced verbal fluency, consistent with frontal dysfunction. On the BIS-11-SF, he scored 36 out of 60. MS had been diagnosed in 2011 after persistent left leg weakness, confirmed by CSF analysis and MRI. Initial therapy with glatiramer acetate was switched to rituximab in 2016 due to radiological and clinical progression, achieving clinical stability.However, cranial MRI in 2022 revealed global cortical atrophy disproportionate to age, most prominent in the bilateral frontal lobes, with confluent subcortical, juxtacortical and periventricular demyelinating lesions (Image 1–3).These findings, attributed to the progressive course of MS, could explain his cognitive, emotional and behavioral symptoms associated with a dysexecutive syndrome.Image 1:

Axial T 2 F L A I R M R I scan showing periventricular hyperintense lesions and significant cortical atrophy. See long description.Image 2:Axial T 2 M R I scan of a brain showing hyperintense demyelinating lesions. Bright white signals are concentrated around the central ventricles and scattered throughout the surrounding white matter.Image 3:

A sagittal M R I scan of a human head using T 2 F L A I R sequencing showing hyperintense lesions and cortical thinning. See long description.

Conclusions

MS with a progressive course may lead to cortical atrophy and neurodegeneration beyond demyelination, causing complex neuropsychiatric symptoms. In this case, frontal atrophy was associated with executive dysfunction, disinhibition and impulsivity. Radiological progression preceded behavioral symptoms and along with MRI evidence of widespread demyelination, supported MS-related neurodegeneration rather than FTD. Recognizing this distinction is essential for accurate diagnosis and appropriate management.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.